Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 4 (2007), Issue 3 (March)

1. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension.
   Circ Res, 100(4): 520-6. [Abstract] [Full-text]
2. Has blood pressure increased in children in response to the obesity epidemic?
   Pediatrics, 119(3): 544-53. [Abstract] [Full-text]
3. Inaccuracy in pediatric outpatient blood pressure measurement.
   Pediatrics, 119(3): e538-43. [Abstract] [Full-text]
4. Circumferential versus longitudinal systolic function in patients with hypertension: a nonlinear relation.
   J Am Soc Echocardiogr, 20(3): 298-306. [Abstract] [Full-text]
5. Neuronal nitric oxide mediates cerebral vasodilatation during acute hypertension.
   Brain Res, 1139: 126-32. [Abstract] [Full-text]
6. Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.
   Clin Pharmacol Ther, 81(3): 386-91. [Abstract] [Full-text]
7. Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.
   Expert Rev Cardiovasc Ther, 5(2): 201-11. [Abstract] [Full-text]
8. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.
   Expert Rev Cardiovasc Ther, 5(2): 147-59. [Abstract] [Full-text]
9. Renin-induced hypertension in Wilms tumor patients.
   Pediatr Blood Cancer, 48(5): 500-3. [Abstract] [Full-text]
10. Hypertension patients participating in trials differ in many aspects from patients treated in general practices.
    J Clin Epidemiol, 60(4): 330-5. [Abstract] [Full-text]
11. Prescribing pattern of antihypertensive drugs in primary care units in Turkey: results from the TURKSAHA study.
    Eur J Clin Pharmacol, 63(4): 397-402. [Abstract] [Full-text]
12. Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study.
    Eur J Clin Pharmacol, 63(4): 389-95. [Abstract] [Full-text]
13. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.
    Eur J Vasc Endovasc Surg, 33(4): 414-21. [Abstract] [Full-text]
14. Event related brain potentials in elderly patients with recently diagnosed isolated systolic hypertension.
    Clin Neurophysiol, 118(4): 824-32. [Abstract] [Full-text]
15. Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction.
    Circulation, 115(10): 1269-74. [Abstract] [Full-text]
16. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level.
    Arch Intern Med, 167(5): 502-6. [Abstract] [Full-text]
17. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
    Life Sci, 80(15): 1364-72. [Abstract] [Full-text]
18. A tool for reliable self-home blood pressure monitoring designed according to the European Society of Hypertension recommendations: the Microlife WatchBP Home monitor.
    Blood Press Monit, 12(2): 127-31. [Abstract] [Full-text]
19. Validation of the Samsung SBM-100A and Microlife BP 3BU1-5 wrist blood pressure measuring devices in adults according to the International Protocol.
    Blood Press Monit, 12(2): 119-25. [Abstract] [Full-text]
20. Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol.
    Blood Press Monit, 12(2): 113-7. [Abstract] [Full-text]
21. The Health and Life device (HL888HA): accuracy assessment in an adult population according to the British Hypertension Society protocol.
    Blood Press Monit, 12(2): 107-11. [Abstract] [Full-text]
22. Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age.
    Blood Press Monit, 12(2): 101-6. [Abstract] [Full-text]
23. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Blood Press Monit, 12(2): 95-9. [Abstract] [Full-text]
24. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Blood Press Monit, 12(2): 87-94. [Abstract] [Full-text]
25. US demographic trends in mid-arm circumference and recommended blood pressure cuffs for children and adolescents: data from the National Health and Nutrition Examination Survey 1988-2004.
    Blood Press Monit, 12(2): 75-80. [Abstract] [Full-text]
26. Blood pressure determination by traditionally trained personnel is less reliable and tends to underestimate the severity of moderate to severe hypertension.
    Blood Press Monit, 12(2): 61-8. [Abstract] [Full-text]
27. Diminished Kv4.2/3 but not KChIP2 levels reduce the cardiac transient outward K+ current in spontaneously hypertensive rats.
    Cardiovasc Res, 74(1): 85-95. [Abstract] [Full-text]
28. Progesterone reduces erectile dysfunction in sleep-deprived spontaneously hypertensive rats.
    Reprod Biol Endocrinol, 5: 7. [Abstract] [Full-text]
29. Factors affecting study efficiency and item non-response in health surveys in developing countries: the Jamaica national healthy lifestyle survey.
    BMC Med Res Methodol, 7: 13. [Abstract] [Full-text]
30. Management of hypertensive emergencies: implications for the critical care nurse.
    Crit Care Nurs Q, 30(2): 86-93. [Abstract] [Full-text]
31. Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial.
    Aust N Z J Obstet Gynaecol, 47(2): 115-21. [Abstract] [Full-text]
32. Systo-diastolic ventricular function in patients with hypertension: an echocardiographic tissue doppler imaging evaluation study.
    Int J Cardiovasc Imaging, 23(2): 177-84. [Abstract] [Full-text]
33. Smoking, hypertension, alcohol consumption, and risk of abdominal aortic aneurysm in men.
    Am J Epidemiol, 165(7): 838-45. [Abstract] [Full-text]
34. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
    Lancet Neurol, 6(4): 373-8. [Abstract] [Full-text]
35. Differential contributions of alpha-1 and alpha-2 adrenoceptors to vasoconstriction in mesenteric arteries and veins of normal and hypertensive mice.
    Vascul Pharmacol, 46(5): 373-82. [Abstract] [Full-text]
36. Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension.
    J Am Coll Cardiol, 49(11): 1157-63. [Abstract] [Full-text]
37. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Endocrinology, 148(4): 1688-96. [Abstract] [Full-text]
38. Effects of renovascular hypertension on reproductive function in male rats.
    Life Sci, 80(17): 1627-34. [Abstract] [Full-text]
39. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats.
    J Pharmacol Exp Ther, 321(1): 381-8. [Abstract] [Full-text]
40. Results of the Women's Health Study of Accra: assessment of blood pressure in urban women.
    Int J Cardiol, 117(1): 115-22. [Abstract] [Full-text]
41. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice.
    J Exp Med, 204(3): 657-66. [Abstract] [Full-text]
42. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Nephrology (Carlton), 12(2): 147-53. [Abstract] [Full-text]
43. Daily blood pressure control is not sufficient to regress cardiac hypertrophy and dysfunction: a bi-ventricular tissue Doppler echocardiographic study.
    Nephrology (Carlton), 12(2): 140-6. [Abstract] [Full-text]
44. Effects of anti-hypertensive drugs on vessel rarefaction.
    Curr Opin Pharmacol, 7(2): 151-7. [Abstract] [Full-text]
45. Physical activity in young adults and incident hypertension over 15 years of follow-up: the CARDIA study.
    Am J Public Health, 97(4): 703-9. [Abstract] [Full-text]
46. Relation between neighborhood median housing value and hypertension risk among black women in the United States.
    Am J Public Health, 97(4): 718-24. [Abstract] [Full-text]
47. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
    Hypertension, 49(4): 878-84. [Abstract] [Full-text]
48. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats.
    Hypertension, 49(4): 926-31. [Abstract] [Full-text]
49. Differences in blood pressure control and stroke mortality across Spain: the Prevención de Riesgo de Ictus (PREV-ICTUS) study.
    Hypertension, 49(4): 799-805. [Abstract] [Full-text]
50. Glutamatergic inputs in the hypothalamic paraventricular nucleus maintain sympathetic vasomotor tone in hypertension.
    Hypertension, 49(4): 916-25. [Abstract] [Full-text]
51. Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats.
    Hypertension, 49(4): 893-901. [Abstract] [Full-text]
52. Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials.
    Hypertension, 49(4): 792-8. [Abstract] [Full-text]
53. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.
    Hypertension, 49(4): 784-91. [Abstract] [Full-text]
54. Effect of spironolactone on blood pressure in subjects with resistant hypertension.
    Hypertension, 49(4): 839-45. [Abstract] [Full-text]
55. Renal sympathetic neuroeffector function in renovascular and angiotensin II-dependent hypertension in rabbits.
    Hypertension, 49(4): 932-8. [Abstract] [Full-text]
56. Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload.
    Hypertension, 49(4): 857-64. [Abstract] [Full-text]
57. Polymorphism of CYP11B2 determines salt sensitivity in Japanese.
    Hypertension, 49(4): 825-31. [Abstract] [Full-text]
58. High blood pressure in pregnancy and coronary calcification.
    Hypertension, 49(4): 813-7. [Abstract] [Full-text]
59. Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation.
    Hypertension, 49(4): 777-83. [Abstract] [Full-text]
60. C-reactive protein is elevated in the offspring of parents with essential hypertension.
    Arch Dis Child, 92(4): 304-8. [Abstract] [Full-text]
61. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.
    Arterioscler Thromb Vasc Biol, 27(4): 762-8. [Abstract] [Full-text]
62. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
    Eur J Hum Genet, 15(4): 478-84. [Abstract] [Full-text]
63. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.
    Mol Pharmacol, 71(4): 1040-50. [Abstract] [Full-text]
64. Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers.
    Metabolism, 56(4): 559-64. [Abstract] [Full-text]
65. The association between customised small for gestational age infants and pre-eclampsia or gestational hypertension varies with gestation at delivery.
    BJOG, 114(4): 478-84. [Abstract] [Full-text]
66. Morning blood pressure at home predicts erythropoietin-induced hypertension in patients with chronic renal diseases.
    Clin Exp Nephrol, 11(1): 66-70. [Abstract] [Full-text]
67. Regulatory mechanism of "K+recycling" for Na +reabsorption in renal tubules.
    Clin Exp Nephrol, 11(1): 1-6. [Abstract] [Full-text]
68. Measurement of aldosterone in feline, canine and human urine.
    J Small Anim Pract, 48(4): 202-8. [Abstract] [Full-text]
69. DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo.
    Brain Res, 1144: 146-55. [Abstract] [Full-text]
70. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension.
    Eur J Pharmacol, 561(1): 129-36. [Abstract] [Full-text]
71. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
    Eur J Pharmacol, 561(1): 144-50. [Abstract] [Full-text]
72. Nodular glomerulosclerosis: renal lesions in chronic smokers mimic chronic thrombotic microangiopathy and hypertensive lesions.
    Am J Kidney Dis, 49(4): 552-9. [Abstract] [Full-text]
73. Evaluation of insulin resistance and sodium sensitivity in normotensive offspring of hypertensive individuals.
    Am J Kidney Dis, 49(4): 540-6. [Abstract] [Full-text]
74. Urinary free cortisol is not a biochemical marker of hypertension.
    Am J Hypertens, 20(4): 459-65. [Abstract] [Full-text]
75. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Am J Hypertens, 20(4): 443-50. [Abstract] [Full-text]
76. Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension.
    Am J Hypertens, 20(4): 437-42. [Abstract] [Full-text]
77. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
    Am J Hypertens, 20(4): 417-22. [Abstract] [Full-text]
78. Family history of hypertension influences left ventricular diastolic function during chronic antihypertensive therapy.
    Am J Hypertens, 20(4): 410-5. [Abstract] [Full-text]
79. High fructose diet increases mortality in hypertensive rats compared to a complex carbohydrate or high fat diet.
    Am J Hypertens, 20(4): 403-9. [Abstract] [Full-text]
80. A whole genome scan for pulse pressure/stroke volume ratio in African Americans: the HyperGEN study.
    Am J Hypertens, 20(4): 398-402. [Abstract] [Full-text]
81. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients.
    Am J Hypertens, 20(4): 392-7. [Abstract] [Full-text]
82. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement.
    Am J Hypertens, 20(4): 385-91. [Abstract] [Full-text]
83. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure.
    Am J Hypertens, 20(4): 378-84. [Abstract] [Full-text]
84. A prospective study of body mass index and the risk of developing hypertension in men.
    Am J Hypertens, 20(4): 370-7. [Abstract] [Full-text]
85. Prognostic value of elevated white blood cell count in hypertension.
    Am J Hypertens, 20(4): 364-9. [Abstract] [Full-text]
86. Acculturation is associated with hypertension in a multiethnic sample.
    Am J Hypertens, 20(4): 354-63. [Abstract] [Full-text]
87. Health insurance status and hypertension monitoring and control in the United States.
    Am J Hypertens, 20(4): 348-53. [Abstract] [Full-text]
88. Hypertensive patients with false-positive thallium-201 scintigraphic results in the infero-posterior wall are in high risk for coronary artery disease development.
    Int J Cardiol, 117(2): 178-83. [Abstract] [Full-text]
89. A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
    Int J Cardiol, 117(2): 152-6. [Abstract] [Full-text]
90. Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.
    Nat Clin Pract Nephrol, 3(4): 208-21. [Abstract] [Full-text]
91. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs.
    J Am Soc Nephrol, 18(4): 1209-17. [Abstract] [Full-text]
92. Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan.
    Stroke, 38(4): 1161-6. [Abstract] [Full-text]
93. The relation between knowledge about hypertension and education in hospitalized patients with stroke in Vienna.
    Stroke, 38(4): 1304-8. [Abstract] [Full-text]
94. Blood pressure and estimated risk of stroke in the elderly population of Spain: the PREV-ICTUS study.
    Stroke, 38(4): 1167-73. [Abstract] [Full-text]
95. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    J Am Soc Nephrol, 18(4): 1262-70. [Abstract] [Full-text]
96. Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
    Fundam Clin Pharmacol, 21(2): 199-205. [Abstract] [Full-text]
97. Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies.
    Fundam Clin Pharmacol, 21(2): 181-90. [Abstract] [Full-text]
98. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    J Intern Med, 261(4): 384-91. [Abstract] [Full-text]
99. Comprehensive linkage and linkage heterogeneity analysis of 4344 sibling pairs affected with hypertension from the Family Blood Pressure Program.
    Genet Epidemiol, 31(3): 195-210. [Abstract] [Full-text]
100. Medications during pregnancy: antihypertensives and immunosuppressives.
     Adv Chronic Kidney Dis, 14(2): 191-8. [Abstract] [Full-text]
101. Hypertension in pregnancy.
     Adv Chronic Kidney Dis, 14(2): 178-90. [Abstract] [Full-text]
102. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
     J Neurochem, 101(1): 41-56. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.